Top Industry Leaders in the Pneumoconiosis Market
3M Company Introduced the Versaflo™ M-3000 Powered Air-Purifying Respirator with PAPR and CPAP options, offering enhanced protection against airborne dust particles associated with pneumoconiosis.
MSA Safety Launched the G1 Pro SCBA (Self-Contained Breathing Apparatus) with improved airflow and communication features, crucial for ensuring worker safety in hazardous environments prone to pneumoconiosis-causing dust.
Honeywell International Developed the Smart Wearable Sensor System, monitoring worker exposure to hazardous dust and providing real-time alerts for improved prevention measures against pneumoconiosis.
Honeywell International Acquired Intelligrated Work Solutions, expanding its portfolio of safety and compliance services, including pneumoconiosis prevention programs for workplaces.
DuPont de Nemours Partnered with the National Institute for Occupational Safety and Health (NIOSH) to research and develop innovative dust suppression technologies for mining and construction industries.
List of Pneumoconiosis Key Companies in the Market
- Abbott (US) Eli Lilly (U.S.)
- Sunpharma (India)
- Sanofi (France)
- Novo Nordisk (Denmark)
- Novartis (Switzerland)
- Abbott (U.S.)
- AstraZeneca (U.K)
- Merck & Co. (U.S.)
- Pfizer (U.S.)
- Svizera Healthcare (India)
- Hoffman La Roche AG (Germany)
- Bayer Cropscience Ltd. (U.S.)